# Roivant Sciences Ltd.: Form SCHEDULE 13D/A, filed Feb 18, 2025

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: SCHEDULE 13D/A
- Filed: 2025-02-18
- Accepted by EDGAR: Feb 18, 2025, 17:21 ET
- Period: not reported
- Accession: 0001140361-25-005025
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000114036125005025/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000114036125005025/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000114036125005025/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-005025. Last ingested by Listed: Nov 11, 2026, 03:12 ET. No prices; not investment advice.